1
|
Pieper C, Engel N, Wend K, Kneuer C, Martin S. In Vitro Human Dermal Absorption Studies on Pesticides in Complex Mixtures: Investigation of Guidance Criteria and Possible Impact Parameters. TOXICS 2024; 12:248. [PMID: 38668471 PMCID: PMC11054108 DOI: 10.3390/toxics12040248] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/21/2024] [Revised: 03/20/2024] [Accepted: 03/28/2024] [Indexed: 04/29/2024]
Abstract
Pesticides must not pose unacceptable risks to human health, so risk assessments are conducted before products are authorised. Dermal exposure is often the main route of intake, so estimating realistic and trustworthy dermal absorption values is crucial for risk assessment. Although there are agreed test guidelines for in vitro dermal absorption studies, not every product is tested due to cost reasons. The present dataset consists of 945 individual in vitro experiments on the dermal absorption of human skin with 179 active substances of pesticides in 353 different mixtures, including concentrates and dilutions. The dataset was evaluated to identify the possible impacts of experimental conditions and physico-chemical properties on dermal absorption. The dataset was also analysed to assess the appropriateness of the pro rata correction for untested dilutions, and the set concentration cut-off to decide on the dilution status for choosing a default value on dermal absorption. The study found that the implementation of specific guidelines improved the harmonisation of study conduct, with support for approaches such as pro rata correction and default values. Further analysis of the specific co-formulants may identify influencing factors that may be more important than the experimental variables.
Collapse
Affiliation(s)
- Christina Pieper
- Department of Pesticides Safety, German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Str. 8-10, 10589 Berlin, Germany (K.W.)
| | | | | | | | | |
Collapse
|
2
|
Kluxen FM, Felkers E, Jensen SM, Domoradzki J, Lorez C, Fisher P, Wiemann C. Practical guidance to evaluate in vitro dermal absorption studies for pesticide registration: An industry perspective. Regul Toxicol Pharmacol 2023:105432. [PMID: 37302560 DOI: 10.1016/j.yrtph.2023.105432] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2023] [Revised: 06/05/2023] [Accepted: 06/08/2023] [Indexed: 06/13/2023]
Abstract
While there are some regulatory assessment criteria available on how to generally evaluate dermal absorption (DA) studies for risk assessment purposes, practical guidance and examples are lacking. The current manuscript highlights the challenges in interpretating data from in vitro assays and proposes holistic data-based assessment strategies from an industry perspective. Inflexible decision criteria may be inadequate for real data and may lead to irrelevant DA estimates. We recommend the use of mean values for reasonably conservative DA estimates from in vitro studies. In cases where additional conservatism is needed, e.g., due to non-robust data and acute exposure scenarios, the upper 95% confidence interval of the mean may be appropriate. It is critical to review the data for potential outliers and we provide some example cases and strategies to identify aberrant responses. Some regional regulatory authorities require the evaluation of stratum corneum (SC) residue, but here, as a very simple pro-rata approach, we propose to review whether the predicted post 24-h absorption flux exceeds the predicted elimination flux by desquamation because otherwise it is not possible for the SC residue to contribute to systemic dose. Overall, the adjustment of DA estimates due to mass balance (normalization) is not recommended.
Collapse
Affiliation(s)
| | | | | | | | | | - Philip Fisher
- Bayer SAS, Crop Science Division, Sophia Antipolis, France
| | | |
Collapse
|
3
|
A new conceptional model for deriving average dermal absorption estimates from studies with multiple tested concentrations for non-dietary risk assessment of pesticides. Arch Toxicol 2022; 96:2429-2445. [PMID: 35704048 PMCID: PMC9325830 DOI: 10.1007/s00204-022-03320-3] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2022] [Accepted: 05/25/2022] [Indexed: 11/18/2022]
Abstract
Dermal absorption values are used to translate external dermal exposure into potential systemic exposure for non-dietary risk assessment of pesticides. While the Environmental Protection Agency of the United States of America (US EPA) derives a common dermal absorption factor for active substances covering all related products, the European Food Safety Authority (EFSA) requests specific product-based estimates for individual concentrations covering the intended use rates. The latter poses challenges, because it disconnects exposure dose from applied dose in absorption studies, which may not be suitable in scenarios where concentration is not relevant. We analyzed the EFSA dermal absorption database, collected 33 human in vitro studies from CropLife Europe (CLE) companies, where ≥3 in-use dilution concentrations were tested, and 15 dermal absorption triple pack datasets. This shows that absolute dermal absorption correlates with absolute applied dose on a decadic logarithm-scale, which is concordant with the toxicological axiom that risk is driven by exposure dose. This method is radically different from the current European approach focused on concentrations and offers new insights into the relationship of internal and external exposure doses when utilizing data from in vitro studies. A single average dermal absorption value can be simply derived from studies with multiple tested concentrations, by calculating the y-intercept of a linear model on a decadic logarithm scale while assuming a slope of 1. This simplifies risk assessment and frees resources to explore exposure refinements. It also serves as a basis to harmonize dermal absorption estimation globally for use in exposure-driven risk assessments.
Collapse
|
4
|
Kluxen FM, Totti S, Maas W, Toner F, Page L, Webbley K, Nagane R, Mingoia R, Whitfield C, Kendrick J, Valentine C, Dorange JB, Egron C, Imart C, Domoradzki JY, Fisher P, Lorez C, McEuen S, Felkers E, Chen T, Wiemann C. An OECD TG 428 study ring trial with 14C-Caffeine demonstrating repeatability and robustness of the dermal absorption in vitro method. Regul Toxicol Pharmacol 2022; 132:105184. [PMID: 35577015 DOI: 10.1016/j.yrtph.2022.105184] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2022] [Revised: 04/19/2022] [Accepted: 05/01/2022] [Indexed: 10/18/2022]
Abstract
The dermal absorption potential of 14C-Caffeine applied as a 4 mg/mL concentration (10 μL/cm2 finite dose) was investigated in six laboratories under Good Laboratory Practice conditions using an OECD TG 428-compliant in vitro assay with flow-through cells and split-thickness human skin. Potential sources of variation were reduced by a standardized protocol, test item and skin source. Particularly, skin samples from same donors were distributed over two repeats and between labs in a non-random, stratified design. Very similar recovery was achieved in the various assay compartments between laboratories, repeats and donors, demonstrating that the assay can be robustly and reliably performed. The absorption in one laboratory was 5-fold higher than in the others. This did not clearly correlate with skin integrity parameters but might be associated with an accidental COVID-19 pandemic-related interruption in sample shipment. It is possible that other factors may affect dermal absorption variation not routinely assessed or considered in the current method. The mean receptor fluid recovery, potential absorption (recovery in receptor fluid and skin except tape strips 1 and 2) and mass balance of caffeine was 6.99%, 7.14% and 99.13%, respectively, across all and 3.87%, 3.96% and 99.00% in the subset of five laboratories.
Collapse
Affiliation(s)
| | | | - Wilfred Maas
- Charles River Laboratories, Den Bosch, the Netherlands
| | - Frank Toner
- Charles River Laboratories, Tranent, United Kingdom
| | - Leanne Page
- Charles River Laboratories, Tranent, United Kingdom
| | | | | | | | | | | | | | | | | | | | | | - Philip Fisher
- Bayer SAS, Bayer Crop Science, Sophia, Antipolis, France
| | | | | | | | - Tao Chen
- University of Surrey, Guildford, United Kingdom
| | | |
Collapse
|
5
|
Mojsiewicz-Pieńkowska K, Krenczkowska D, Bazar D, Wielgomas B, Cal K, Kaliszan M. Comparative study of the percutaneous permeation and bioaccumulation of the cyclic siloxane using frozen-thawed and nonfrozen ex vivo human skin. Toxicol In Vitro 2022; 82:105379. [PMID: 35561954 DOI: 10.1016/j.tiv.2022.105379] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2021] [Revised: 04/06/2022] [Accepted: 05/06/2022] [Indexed: 11/25/2022]
Abstract
Literature shows contradictory information regarding the effect of freezing the excise skin ex vivo on the diffusion of substances into the skin. Few studies indicate that storing the human or animal skin in a frozen state decreases the barrier properties after thawing. Therefore, to understand the properties of frozen skin, we evaluated the effect of storage of ex vivo human skin (2 weeks at -20 °C) on the penetration of stratum corneum and permeation into deeper skin layers (epidermis, and dermis) as well as to the receptor fluid by octamethylcyclotetrasiloxane (D4) a representative test compound of cyclic siloxanes. The main research were preceded by checking the integrity of nonfrozen ex vivo human skin in comparison to the frozen-thawed one by using the Electrical Resistance technique (ER) and the fluorescence microscopy. Samples collected in the skin absorption experiment were analyzed by gas chromatography equipped with a flame ionization detector (GC-FID). The results of this study demonstrated that freezing of excised ex vivo human skin at -20 °C for up to 14 days does not alter the permeability of D4 in a statistically significant manner. Thus, our results confirmed the validity of using skin storage conditions for testing the penetration and permeation of xenobiotics recommended by the OECD, EMA, and WHO guidelines.
Collapse
Affiliation(s)
- Krystyna Mojsiewicz-Pieńkowska
- Department of Physical Chemistry, Faculty of Pharmacy, Medical University of Gdańsk, Al. Gen. Józefa Hallera 107, 80-416 Gdańsk, Poland.
| | - Dominika Krenczkowska
- Department of Physical Chemistry, Faculty of Pharmacy, Medical University of Gdańsk, Al. Gen. Józefa Hallera 107, 80-416 Gdańsk, Poland
| | - Dagmara Bazar
- Department of Physical Chemistry, Faculty of Pharmacy, Medical University of Gdańsk, Al. Gen. Józefa Hallera 107, 80-416 Gdańsk, Poland
| | - Bartosz Wielgomas
- Department of Toxicology, Faculty of Pharmacy, Medical University of Gdańsk, Al. Gen. Józefa Hallera 107, 80-416 Gdańsk, Poland
| | - Krzysztof Cal
- Department of Pharmaceutical Technology, Faculty of Pharmacy, Medical University of Gdańsk, Al. Gen. Józefa Hallera 107, 80-416 Gdańsk, Poland
| | - Michał Kaliszan
- Department of Forensic Medicine, Faculty of Medicine, Medical University of Gdańsk, ul. Dębowa 23, 80-204 Gdańsk, Poland
| |
Collapse
|
6
|
Kluxen FM, Felkers E, Baumann J, Morgan N, Wiemann C, Stauber F, Strupp C, Adham S, Kuster CJ. Compounded conservatism in European re-entry worker risk assessment of pesticides. Regul Toxicol Pharmacol 2021; 121:104864. [PMID: 33450327 DOI: 10.1016/j.yrtph.2021.104864] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2020] [Revised: 12/18/2020] [Accepted: 01/08/2021] [Indexed: 01/04/2023]
Abstract
We review the risk parameters and drivers in the current European Union (EU) worker risk assessment for pesticides, for example considering crop maintenance, crop inspection or harvesting activities, and show that the current approach is very conservative due to multiple worst-case default assumptions. As a case study, we compare generic exposure model estimates with measured worker re-entry exposure values which shows that external cumulative exposure is overpredicted by about 50-fold on average. For this exercise, data from 16 good laboratory practice (GLP)-compliant worker exposure studies in 6 crops were evaluated with a total number of 184 workers. As generic overprediction does not allow efficient risk management or realistic risk communication, we investigate how external exposure can be better predicted within the generic model, and outline options for possible improvements in the current methodology. We show that simply using averages achieves more meaningful exposure estimates, while still being conservative, with an average exposure overprediction of about 9-fold. Overall, EU risk assessment includes several numerically unaccounted "hidden safety factors", which means that workers are well protected; but simultaneously risk assessments are biased towards failing due to compounded conservatism. This should be considered for further global or regional guidance developments and performing more exposure-relevant risk assessment.
Collapse
Affiliation(s)
| | | | | | | | | | - Franz Stauber
- BASF SE, Agricultural Solutions, Ludwigshafen, Germany
| | | | - Sarah Adham
- Corteva Agriscience, Abingdon, United Kingdom
| | | |
Collapse
|
7
|
Response to "OECD 428 in vitro dermal absorption mass balance performance based on our in-house database of pesticide studies". Regul Toxicol Pharmacol 2020; 115:104707. [PMID: 32512117 DOI: 10.1016/j.yrtph.2020.104707] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2020] [Revised: 05/25/2020] [Accepted: 06/04/2020] [Indexed: 11/22/2022]
|
8
|
Heylings J. OECD 428 in vitro dermal absorption mass balance performance based on our in-house database of pesticide studies. Regul Toxicol Pharmacol 2020; 113:104612. [PMID: 32061759 DOI: 10.1016/j.yrtph.2020.104612] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2020] [Accepted: 02/06/2020] [Indexed: 02/03/2023]
Affiliation(s)
- Jon Heylings
- Dermal Technology Laboratory Ltd, Med IC4, Keele University Science and Business Park, ST5 5NL, United Kingdom
| |
Collapse
|